Cargando…
Radiation-Associated Angiosarcoma as a Presentation of Disease Progression in a Patient on Immunotherapy for Metastatic Non-small Cell Lung Cancer
Non-small cell lung cancer (NSCLC) is the dominant form of lung cancer, comprising around 85% of cases. Stage 4 NSCLC has a grim prognosis; however, immunotherapy and radiation therapy have become vital treatments for advanced-stage NSCLC, despite the risk of inducing a second primary malignancy. Th...
Autores principales: | Tan, Hannah, Torere, Beatrice E, Okun, Sherry, Hinton, Benjamin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10552933/ https://www.ncbi.nlm.nih.gov/pubmed/37809227 http://dx.doi.org/10.7759/cureus.44724 |
Ejemplares similares
-
Salvage Hypofractionated Radiotherapy in a Progressive Radiation-Induced Angiosarcoma: A Case Report
por: Bonzano, Elisabetta, et al.
Publicado: (2017) -
Low Radiologic Sensitivity in Detecting Radiation-Associated Breast Angiosarcoma (RAS)
por: Fakhry, Jonathan, et al.
Publicado: (2023) -
The Association of Radiation Dose-Fractionation and Immunotherapy Use With Overall Survival in Metastatic Melanoma Patients
por: Wang, Shang-Jui, et al.
Publicado: (2020) -
Complete Response of Metastatic Melanoma to Local Radiation and Immunotherapy: 6.5 Year Follow-Up
por: Gutkin, Paulina M, et al.
Publicado: (2018) -
Has the practice of radiation oncology for locally advanced and metastatic non-small-cell lung cancer changed in Canada?
por: Han, K., et al.
Publicado: (2010)